Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.38 |
| ▸ | PRKDC | P78527 | 1/20 | 0.38 |
| ▸ | PLA2G2A | P14555 | 3/20 | 0.37 |
| ▸ | PLA2G4A | P47712 | 3/20 | 0.37 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.36 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.36 |
| ▸ | ESR1 | P03372 | 2/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | CA1 | P00915 | 2/20 | 0.35 |
| ▸ | CA2 | P00918 | 2/20 | 0.35 |
| ▸ | MMP12 | P39900 | 1/20 | 0.35 |
| ▸ | MMP13 | P45452 | 1/20 | 0.35 |
| ▸ | PGR | P06401 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 4/20 | 0.34 |
| ▸ | MEN1 | O00255 | 3/20 | 0.34 |
| ▸ | MAPT | P10636 | 3/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13507984 | 0.95 | ERAP1 (0.39) | ERAP1PRKDCPLA2G2APLA2G4AESR1 | |
| SCHEMBL17943893 | 0.94 | ERAP1 (0.37) | ERAP1PRKDCPLA2G2APLA2G4APTPN2 | |
| SCHEMBL13508030 | 0.93 | PRKDC (0.41) | ERAP1PRKDCPLA2G2APLA2G4APTPN2 | |
| SCHEMBL16067723 | 0.91 | ERAP1 (0.37) | ERAP1PRKDCPLA2G2APLA2G4AESR1 | |
| SCHEMBL16068064 | 0.90 | PLA2G2A (0.37) | ERAP1PRKDCPLA2G2APLA2G4APTPN2 | |
| SCHEMBL17577237 | 0.90 | PLA2G2A (0.36) | ERAP1PRKDCPLA2G2APLA2G4APTPN2 | |
| SCHEMBL17577243 | 0.90 | PLA2G2A (0.36) | ERAP1PRKDCPLA2G2APLA2G4APTPN2 | |
| SCHEMBL19108691 | 0.90 | PLA2G2A (0.39) | ERAP1PRKDCPLA2G2APLA2G4APTPN1 | |
| SCHEMBL16067711 | 0.89 | ERAP1 (0.38) | ERAP1PRKDCPLA2G2APLA2G4AESR1 | |
| SCHEMBL13507115 | 0.89 | PLA2G2A (0.41) | ERAP1PRKDCPLA2G2APLA2G4APTPN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100032658-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-02-11 | — | — | US | disclosed |
| US-20100032658-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-02-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100032658-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | OCIAD1, OCIAD2, ORMDL3 | ERAP1 3959/4885PRKDC 4484/4885PLA2G2A 3711/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.